Synthomer swings to positive full-year free cash flow.


Synthomer sounded a positive note on the outlook, despite having swung to negative free cash flow on a full-year basis.

  • Synthomer
  • 11 March 2025 08:29:05
Calculator

Source: Sharecast

The specialised polymers and ingredients manufacturer forecast that it would turn free cash flow positive in 2025 and reduce debt "even without a significant improvement in market conditions".

Management also indicated that trading since the start of the year had been in line with its expectations for a "muted" start to 2025 in comparison to the relatively strong first three months of 2024.

For the year ending on 31 December, revenues edged up by 2.4% to £1.94bn or 5.1% at constant currencies.

On an underlying basis, earnings before interest and tax improved by 50.9% to £50.4m.

The underlying loss before tax meanwhile was pared from £31.1m one year before to £7.2m.

Free cash flow worsened to -£54.7m from £85.7m one year before, as a result of a non-recurring EC fine settlement, deferred pension contributions and the reduced use of a committed receivables financing facility at the end of the year.

Net debt increased 20% to £597m.


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.